Biosense Company

Biosense has a mission to help patients better manage their own health by providing novel, clinically-backed tools to easily measure breath biomarkers. Biosense, was launched in early 2020 as a Class 1 medical device in the clinical, consumer, and research market after a successful clinical trial. As the only clinically-backed breath ketone measurement handheld device+app, Biosense provides full-day feedback of ketosis with unlimited measurements leading to protocol adherence and better outcomes. Biosense is used by obesity and diabetes clinics for in-home testing of ketosis, pharma and academic trials, as well as DTC.
Technology: NeuroTech
Industry: Biomarkers for Longevity
Headquarters: St Louis, Missouri, United States
Zip: 11-50
Founded Date: 2018-07-11
Employees Number: 11-50
Acquisitions Number: 4
Investors Number: 3055890
Total Funding: Less than $1M
Estimated Revenue: Less than $1M
Last Funding Date: Debt Financing
Last Funding Type:

Visit Website
Register and Claim Ownership